The Pharmacokinetics of a Hemp-Based Topical Product

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Johns Hopkins University
Study ID
NCT07603518
Phase
PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cannabis

Eligibility Criteria

Sex
ALL
Age
18 Years - 55 Years
Healthy Volunteers
Accepted

Interventions

  • CBD — DRUG
    CBD will be topically applied
  • THC — DRUG
    THC will be topically applied

Study Details

This study will evaluate the pharmacokinetic effects of acute and chronic dosing of a hemp-based cannabidiol (CBD) topical lotion with low levels of delta-9-tetrahydrocannabinol (THC) in a sanitized and controlled environment.

Key Dates

Start date
Jun 30, 2026
Status verified
May 2026
Primary completion
Aug 31, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Topical CBD Product with low level of THC
    Participants will topically apply a high CBD-product that also contains low levels of THC.

Primary Outcome Measure

Change in concentration of oral fluid cannabinoids [ Time Frame: Days 1-7 and Day 14 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Behavioral Pharmacology Research UnitBaltimoreMaryland21224
Tory Spindle, Ph.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Baltimore, MD

By research site
Behavioral Pharmacology Research Unit· Baltimore, MD

Related Studies